| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |